Artificial Intelligence Revolutionizes Merchant API Manufacturing as Market Expands at 6.97% CAGR
10 nov. 2023 08h28 HE
|
Research and Markets
Dublin, Nov. 10, 2023 (GLOBE NEWSWIRE) -- The "Global Merchant API Market (by Molecular Type, Segment, Type, Type of Synthesis, End-User, & Region): Insights and Forecast with Potential Impact...
Novacap completes the acquisition of PCI Synthesis and expands its pharmaceutical offerings in the U.S.
28 juin 2018 12h01 HE
|
PCI Synthesis; Novacap
LYON, France and NEWBURYPORT, Mass., June 28, 2018 (GLOBE NEWSWIRE) -- Novacap, a worldwide player in pharmaceutical synthesis and advanced specialties, announced today that it has completed the...
Novacap to expand its pharmaceutical offering in the U.S. with the acquisition of PCI Synthesis
20 juin 2018 12h03 HE
|
PCI Synthesis; Novacap
LYON, France and NEWBURYPORT, Mass., June 20, 2018 (GLOBE NEWSWIRE) -- Novacap, a worldwide player in pharmaceutical synthesis and advanced specialties, announced today that it has signed an...
PCI Synthesis Submits Patent for Synthesizing Azelaic Acid
30 janv. 2018 09h15 HE
|
PCI Synthesis
NEWBURYPORT, Mass., Jan. 30, 2018 (GLOBE NEWSWIRE) -- PCI Synthesis, Inc. (www.pcisynthesis.com), a pharmaceutical manufacturer of new chemical entities (NCEs), generic active pharmaceutical...
PCI Synthesis Identifies Trends Affecting the Generic Drugs Sector in 2018
18 déc. 2017 09h15 HE
|
PCI Synthesis
NEWBURYPORT, Mass., Dec. 18, 2017 (GLOBE NEWSWIRE) -- PCI Synthesis, Inc. (www.pcisynthesis.com), a pharmaceutical manufacturer of new chemical entities (NCEs), generic active pharmaceutical...
Scott VanderWel Joins PCI Synthesis as Business Development Manager
15 nov. 2017 10h15 HE
|
PCI Synthesis
NEWBURYPORT, Mass., Nov. 15, 2017 (GLOBE NEWSWIRE) -- PCI Synthesis, Inc. (www.pcisynthesis.com), a pharmaceutical manufacturer of new chemical entities (NCEs), generic active pharmaceutical...